These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Formation of 13,14-dihydro-prostaglandin E1 during intravenous infusions of prostaglandin E1 in patients with peripheral arterial occlusive disease. Peskar BA; Hesse WH; Rogatti W; Diehm C; Rudofsky G; Schweer H; Seyberth HW Prostaglandins; 1991 Mar; 41(3):225-8. PubMed ID: 1852896 [TBL] [Abstract][Full Text] [Related]
9. PGE1 reduces collagen and glycosaminoglycan synthesis in rabbit aorta. Sinzinger H; Zidek T; Rogatti W Exp Pathol; 1988; 33(2):119-22. PubMed ID: 3396651 [TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E1 dose-dependently promotes stability of atherosclerotic plaque in a rabbit model. Bai W; Zheng X; Zhou L; Li H Can J Physiol Pharmacol; 2012 Feb; 90(2):131-9. PubMed ID: 22309388 [TBL] [Abstract][Full Text] [Related]
11. [Metabolism of intravenously administered prostaglandin E1 in patients with peripheral arterial occlusive disease]. Hesse WH; Rudofsky G; Peskar BA Wien Klin Wochenschr; 1991; 103(18):554-7. PubMed ID: 1750222 [TBL] [Abstract][Full Text] [Related]
12. 6-Keto-prostaglandin E1 is a potent coronary vasodilator and stimulates a vagal reflex in dogs. Panzenbeck MJ; Hintze TH; Kaley G J Pharmacol Exp Ther; 1988 Mar; 244(3):814-9. PubMed ID: 3075239 [TBL] [Abstract][Full Text] [Related]
14. Protective effect of prostaglandin E₁ on radiation-induced proliferative inhibition and apoptosis in keratinocytes and healing of radiation-induced skin injury in rats. Takikawa M; Sumi Y; Tanaka Y; Nambu M; Doumoto T; Yanagibayashi S; Azuma R; Yamamoto N; Kishimoto S; Ishihara M; Kiyosawa T J Radiat Res; 2012; 53(3):385-94. PubMed ID: 22739008 [TBL] [Abstract][Full Text] [Related]
15. On the metabolism of prostaglandin E1 administered intravenously to human volunteers. Peskar BA; Cawello W; Rogatti W; Rudofsky G J Physiol Pharmacol; 1991 Sep; 42(3):327-31. PubMed ID: 1793892 [TBL] [Abstract][Full Text] [Related]
16. Formation of biologically active 13,14-dihydro-prostaglandin E1 during intravenous infusion of prostaglandin E1 in newborns with ductus arteriosus-dependent congenital heart disease. Leonhardt A; Schweer H; Wolf D; Seyberth HW Br J Clin Pharmacol; 1992 Mar; 33(3):323-5. PubMed ID: 1576056 [TBL] [Abstract][Full Text] [Related]
17. Increase in in vivo low-density lipoprotein (LDL) receptor binding after PGE1 and 13,14-dihydro-PGE1 treatment in rabbits. Sinzinger H; Virgolini I; Li SR; Gerakakis A; Fitscha P; O'Grady J J Cardiovasc Pharmacol; 1993 Mar; 21(3):503-6. PubMed ID: 7681515 [TBL] [Abstract][Full Text] [Related]
18. Effect of prostaglandin (PG) E1 and its initial metabolites on neutrophil-induced inhibition of human platelet aggregation. Pallapies D; Peskar BA Thromb Res; 1993 Aug; 71(3):217-25. PubMed ID: 8211888 [TBL] [Abstract][Full Text] [Related]
19. Long-lasting depression of rabbit aortic prostacyclin formation by single-dose irradiation. Sinzinger H; Cromwell M; Firbas W Radiat Res; 1984 Mar; 97(3):533-6. PubMed ID: 6374740 [TBL] [Abstract][Full Text] [Related]
20. [Prostacyclin- and thromboxane synthesis in the vascular wall after gammatron irradiation]. Sinzinger H; Cromwell M; Firbas W Strahlenther Onkol; 1986 Sep; 162(9):592-5. PubMed ID: 3532388 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]